{"organizations": [], "uuid": "5fd0a24d824bb07324cff5dbcb5b50c383262f3a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-apricus-biosciences-says-co-receiv/brief-apricus-biosciences-says-co-received-a-nasdaq-staff-deficiency-letter-idUSFWN1RT0T5", "country": "US", "domain_rank": 408, "title": "BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T23:16:00.000+03:00", "replies_count": 0, "uuid": "5fd0a24d824bb07324cff5dbcb5b50c383262f3a"}, "author": "", "url": "https://www.reuters.com/article/brief-apricus-biosciences-says-co-receiv/brief-apricus-biosciences-says-co-received-a-nasdaq-staff-deficiency-letter-idUSFWN1RT0T5", "ord_in_thread": 0, "title": "BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter", "locations": [], "entities": {"persons": [], "locations": [{"name": "co", "sentiment": "none"}], "organizations": [{"name": "brief-apricus biosciences says co", "sentiment": "negative"}, {"name": "apricus biosciences inc", "sentiment": "none"}, {"name": "sec", "sentiment": "none"}, {"name": "staff deficiency letter reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 16, 2018 / 8:17 PM / Updated 5 minutes ago BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter Reuters Staff 1 Min Read \nApril 16 (Reuters) - Apricus Biosciences Inc: \n* APRICUS BIOSCIENCES SAYS ON APRIL 10, CO RECEIVED A NASDAQ STAFF DEFICIENCY LETTER - SEC FILING Source : bit.ly/2JMowAJ Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-04-16T23:16:00.000+03:00", "crawled": "2018-04-16T23:31:31.024+03:00", "highlightTitle": ""}